Melaku Getahun Feleke

Mr. Melaku Getahun Feleke

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Veterinary Medicine: Research and Reports
Verified
Journal Article
Open access
PDF file
YTYesuneh Tefera
Yesuneh Tefera
SNSete Nigussie
Sete Nigussie
WAWegayehu Ashagre
Wegayehu Ashagre
MFMelaku Getahun Feleke
Melaku Getahun Feleke
AWAbibo Wondie
Abibo Wondie
Bereket DessalegnBereket Dessalegn
Bereket Dessalegn
Background: The intentional and illegal misrepresentation of fake medications involves falsely indicating their source. These fraudulent medications can include products that contain either accurate or incorrect ingredients, lack proper labeling, have insufficient quantities of ingredients, and are packaged with counterfeit packaging. This unlawful activity has led to treatment failures, the development of antibiotic resistance, adverse effects, and even deaths. Hence, the objective of this study was to assess the knowledge, practice, and regulatory status of veterinary drug experts in the central Gondar zone of Ethiopia regarding counterfeit veterinary medications. Methods: From January 2023 to July 2023, a self-administered structured questionnaire was utilized to conduct a cross-sectional study in Central Gondar Zone, Ethiopia. The analysis of the data involved the application of descriptive and chi-square tests. Results: The study revealed that the majority of professionals possessed a work experience ranging from 5 to 9 years (23; 56.1%). Additionally, a total of 25 individuals (61.0%) who participated in the research had not undergone any kind of training. It was observed that a significant proportion of participants (82.9%) possessed knowledge about counterfeit veterinary drugs. Only about 63% and 36% of respondents had high knowledge and good practice concerning veterinary counterfeit drugs, respectively. Only 29.3% of participants have reported practices. Furthermore, a poor regulatory level of coordination was detected (85.4%). The study revealed a significant (χ 2 =7.6165; p = 0.022) disparity between the respondents’ practice levels and training. Respondents’ regulatory levels were also significantly associated (p < 0.05) with their sex (χ 2 = 13.34; p = 0.001) and work experience (χ 2 = 13.64; p = 0.033). The research findings also revealed a noteworthy correlation between practice and regulatory activity (χ 2 = 15.0463; p = 0.005). Conclusion: The study outlines the necessity of awareness initiatives, with a focus on the significance of veterinary experts’ knowledge, practice, and regulatory efforts in addressing the issue of counterfeit veterinary medications.

1 January 2025 in Veterinary Medicine International
Verified
Journal Article
Open access
AMAbibo Wondie Mekonen
Abibo Wondie Mekonen
NSNatinael Senbato
Natinael Senbato
MFMelaku Getahun Feleke
Melaku Getahun Feleke
MBMerawi Kindu Birhanie
Merawi Kindu Birhanie
YTYesuneh Tefera
Yesuneh Tefera
Animal diseases pose a significant threat to both animal welfare and productivity, making veterinary drugs essential for their prevention, treatment, and control. In developing countries including Ethiopia, several challenges such as limited drug availability, inadequate storage facilities, improper handling, and insufficient knowledge among veterinary professionals impede the delivery of effective veterinary health services. This study aimed to assess the availability of veterinary drugs, storage conditions, and the knowledge, attitudes, and practices (KAP) of veterinary professionals regarding the safe management of these drugs. A cross‐sectional study was conducted across 46 veterinary facilities (34 government clinics and 12 private pharmacies), involving 170 veterinary professionals who participated through structured questionnaires and observational checklists. Data were analyzed using SPSS and Microsoft Excel. The study revealed suboptimal drug availability, with multivitamins being the most commonly available (84.8%), followed by anthelmintic (72.8%) and antibacterial (69.6%), while antifungals were the least available (18.3%). Storage conditions were inadequate in both government clinics (64.5%) and private retailers (65.6%), falling below the acceptable threshold of over 80% for good storage practice. In terms of KAP, 52.4% of professionals demonstrated low knowledge, 77.6% held negative attitudes, and 50.6% exhibited poor practices related to the safe handling and storage of veterinary drugs. These results indicate critical gaps in drug availability, storage standards, and professional competence. Addressing these challenges requires coordinated action from the Regional Livestock and Agricultural Bureau and the Ethiopian Agricultural Authority (EAA), with emphasis on strengthening supply chains, upgrading storage infrastructure, and implementing targeted training programs for veterinary professionals.

28 May 2026 in PLOS ONE
Verified
Journal Article
Open access
THTewodros Denekew Haile
Tewodros Denekew Haile
AAAyenew Ashenef
Ayenew Ashenef
CDChilot Abiyu Demeke
Chilot Abiyu Demeke
YAYeniewa Kerie Anagaw
Yeniewa Kerie Anagaw
AMAbibo Wondie Mekonen
Abibo Wondie Mekonen
MFMelaku Getahun Feleke
Melaku Getahun Feleke
Background: In vitro dissolution is a critical quality control test in pharmaceutical development, used to measure the rate and extent at which an active pharmaceutical ingredient (API) is released from solid dosage forms, such as tablets, into solution under standardized conditions. It serves as a predictive tool for in vivo drug behavior, providing insights into drug release mechanisms and ensuring the development of robust, effective, and consistent products. Despite its importance, data on dissolution performance remain limited for certain drugs. As a rapid, reliable, and cost-effective method to estimate drug absorption, this study focused on evaluating the dissolution profiles of different brands of ciprofloxacin 500 mg tablets and applying kinetic modeling to support regulatory decision-making. Methods: Twenty samples of ciprofloxacin 500 mg tablets were collected from retail outlets in six selected sites of the West Gondar Zone including Humera, Mai Kadra, Metema, Gendawuha, Kokit, and Midregenet towns between January and July 2022. The samples were obtained from purposively selected outlets using prescription papers issued by the University of Gondar Comprehensive Hospital, following a mystery shopper approach in line with WHO (2015) strategies. All collected samples were transported to the Ethiopian Food and Drug Authority (EFDA) laboratory and conducted as per USP specification. The amount of ciprofloxacin released was quantified using UV-Vis spectrophotometry at 276 nm. While the onset of pharmacological action was not directly measured, the Mean Dissolution Time (MDT) values suggested differences in release rates, which may influence the onset of action in vivo were considered. Dissolution profiles were evaluated using both model-independent parameters (difference factor f₁, similarity factor f₂, dissolution efficiency, and mean dissolution time) and model-dependent kinetics. Results were presented in tables, figures, and narrative form. Results: All of the included tablet brands complied with single-point dissolution study test, as their Active Pharmaceutical Ingredient release were greater than 80% within the specified 30 minutes time frame according to USP standards. Only 4 brands (21.05%) met the f1/f2 similarity criteria. However, fifteen brands (78.95%) were not interchangeable with the comparator, as the difference factors (f1) were greater than 15% and the similarity factor (f2) were less than 50%. The mean dissolution time values ranged between 1.02 and 7.16 minutes, and the results showed that four of the twenty brands (4/20) exhibited the fastest dissolution rate and onset of action. The evaluated brands followed the Korsmeyer-Peppas and Weibull curve approach (the highest coefficient of determination) for the release of drug substances from the dosage forms. Conclusion: The study reveals that while all tested ciprofloxacin 500 mg tablet brands complied with USP single-point dissolution criteria, only 21.05% met the similarity factor (f₂) and difference factor (f₁) standards for interchangeability with the comparator product. Significant variability in dissolution profiles among brands raises concerns regarding bioequivalence and potential implications for therapeutic efficacy and antimicrobial resistance. These findings underline the necessity for enhanced regulatory oversight, including routine dissolution profiling and, where appropriate, in vivo bioequivalence studies to ensure the quality and interchangeability of multisource ciprofloxacin products in Ethiopia and similar settings.

9 August 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MFMelaku Getahun Feleke
Melaku Getahun Feleke
MEMustefa Hinika Edao
Mustefa Hinika Edao
GYGetachew Alemu Yilhal
Getachew Alemu Yilhal
YMYesuneh Tefera Mekasha
Yesuneh Tefera Mekasha
AMAbibo Wondie Mekonen
Abibo Wondie Mekonen
KGKalkidan Getnet
Kalkidan Getnet
Pseudomonas fluorescens ( P. fluorescens ) is an opportunistic Gram-negative bacterium associated with disease in freshwater and marine fish, resulting in economic losses to aquaculture. This study aimed to isolate and identify P. fluorescens from wild Nile tilapia ( Oreochromis niloticus ) and African catfish ( Clarias gariepinus ) collected from Lake Haramaya, Ethiopia, and to evaluate the antimicrobial susceptibility profile of the isolates. A cross-sectional study was conducted from December 2022 to May 2023. A total of 50 fish (32 Nile tilapia and 18 African catfish) were sampled, and 250 swab specimens were collected from the skin, gills, intestine, liver, and kidney. Isolation and identification were performed using conventional cultural, morphological, and biochemical methods. Antimicrobial susceptibility testing was conducted on 10 representative presumptive isolates using the Kirby–Bauer disk diffusion method according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Presumptive P. fluorescens was detected in 21 of 50 (42.0%) wild fish examined. A total of 27 presumptive isolates were recovered from the sampled organs based on their cultural, morphological, and biochemical characteristics. The highest isolate-level occurrence was observed in the skin (20%), followed by the intestine (14%), gills (12%), liver (6%), and kidney (2%). Bacterial occurrence differed significantly among organs ( P < 0.05), whereas no significant association was observed with fish species or sex ( P > 0.05). Among the 10 representative isolates tested, all were resistant to tetracycline and ciprofloxacin, whereas 90% and 70% were susceptible to kanamycin and gentamicin, respectively. These findings provide preliminary evidence of the occurrence of presumptive P. fluorescens and antimicrobial-resistant isolates in wild fish from Lake Haramaya. Molecular confirmation of species identity and comprehensive antimicrobial susceptibility testing using a larger number of isolates are needed, as identification was based solely on phenotypic methods and antimicrobial susceptibility testing was limited to 10 representative isolates. The findings establish baseline information for future surveillance of P. fluorescens and antimicrobial resistance in Ethiopian freshwater ecosystems within a One Health framework.

3 June 2025
Verified
Journal Article
Open access
PDF file
ATAbraham Belete Temesgen
Abraham Belete Temesgen
TMTadegegn Mitiku
Tadegegn Mitiku
MBMastewal Birhan
Mastewal Birhan
MKMersha Chanie Kebede
Mersha Chanie Kebede
MYMohammed Yesuf
Mohammed Yesuf
SSSamuel Atalay Shiferaw
Samuel Atalay Shiferaw
Fasciolosis is a neglected zoonotic parasitic disease caused by Fasciola hepatica and Fasciola gigantica. It is a serious public health and veterinary concern, with significant consequences for both human and livestock populations. An abattoir-based crosssectional study was conducted from January to September 2023 at Gondar ELFORA Abattoir, Northwest Ethiopia, to assess haematobiochemical alterations and pathological lesions induced by fasciolosis in slaughtered cattle. The study included one hundred apparently healthy male local-breed cattle, divided into two groups of fifty: one infected and one non-infected. Cattle were selected using a purposive sampling technique. Infected cattle showed significantly lower mean values for haemoglobin (HGB), haematocrit (HCT), mean corpuscular volume (MCV), total erythrocyte count (TEC), lymphocytes, monocytes, total protein, albumin and glucose compared to non-infected cattle. Conversely, they had higher mean values for mean corpuscular haemoglobin concentration (MCHC), total leukocyte count (TLC), neutrophils, eosinophils, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP). Basophil levels were similar in both groups. Liver alterations observed in acute fasciolosis included hepatomegaly with rounded edges and the presence of juvenile flukes within the parenchyma, while in chronic fasciolosis, the liver appeared smaller and firm, with a corrugated capsule and dilated bile ducts containing twisted flukes. Microscopically, acute fasciolosis showed eosinophil infiltration, hemosiderin pigmentation and congestion around the central vein and sinusoids, whereas chronic fasciolosis showed fibrosis, bile duct proliferation, and metaplasia of epithelial cells from columnar to cuboidal. The observed findings indicate a severe hepatic and systemic disease process driven by parasitic infection, resulting in significant compromise of the cattle’s health. Therefore, regular screening and effective deworming are essential to control bovine fasciolosis, especially in high-risk abattoirs. Haematology and biochemical tests should be part of routine diagnosis for early detection and liver function assessment, while histopathology confirms the infection stage. Enhancing stakeholder awareness and training is vital and further research on seasonal patterns, risk factors and drug resistance is needed to improve control strategies.

9 July 2026 in Veterinary Medicine and Science
Verified
Journal Article
Open access
PDF file
YTYesuneh Tefera
Yesuneh Tefera
STSisaynesh Tarekegn
Sisaynesh Tarekegn
MSMulukan Akalu Shiferaw
Mulukan Akalu Shiferaw
MTMelese Tilahun
Melese Tilahun
NTNasibu Tilahun
Nasibu Tilahun
SBSileshi Belew
Sileshi Belew
Background: Veterinary pharmaceuticals often enter into ecosystems through the disposal of unused and expired medicines and animal excreta. Consequently, these substances are emerging as a global threat, posing risks to ecosystems, biodiversity and public health. However, despite the increasing concerns attributed to veterinary pharmaceuticals, there is a lack of empirical data regarding awareness and practices related to ecopharmacovigilance (EPV) among veterinary professionals in Ethiopia. EPV is an emerging discipline focused on the detection, evaluation, understanding and the prevention of the environmental impacts of pharmaceuticals. This knowledge gap highlights the need for evidence‐based assessment of veterinary professionals’ awareness and practices of EPV in Ethiopia. Therefore, this study aimed to assess veterinary professionals’ knowledge, attitudes and practices (KAP) regarding EPV and pharmaceutical waste management. Methods: A cross‐sectional survey was conducted between January 2024 and May 2025 among 37 veterinary healthcare providers in and around Gondar City. The data were collected using a structured, self‐administered questionnaire. Data were analysed using SPSS version 25 through descriptive statistics and chi‐square tests to identify associations between socio‐demographic characteristics and KAP indicators. Results: The study found that 73% of respondents had never heard of EPV, 78.4% had not received relevant training, and 67.6% reported the absence of pharmaceutical disposal guidelines in their facilities. Although 94.6% acknowledged the harmful effects of improper drug disposal on human and environmental health, only 16.2% were familiar with the term EPV. Knowledge was marginally associated with reading scientific literature ( p = 0.084), whereas attitudes were significantly related to prior knowledge ( p = 0.001), training ( p = 0.001) and reviewing related reports ( p = 0.001). Practices were influenced by prior knowledge ( p = 0.023) and engagement with literature ( p = 0.032). About 40.5% of participants disposed of pharmaceuticals in regular trash, and only 27% returned unused drugs to appropriate authorities. Overall, 62.8% of respondent's demonstrated poor knowledge, 56.8% held negative attitudes, and practices were inadequate. Conclusion: This baseline study reveals low awareness of EPV and poor waste management practices among veterinary healthcare providers. The study shows the urgent need for targeted training, policy enforcement and the integration of environmental education into veterinary curricula in Ethiopia. This is necessary to promote responsible pharmaceutical stewardship and safeguard the environment and public health.